Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity.
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.